- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02750241
Pink Warrior-Support Group Toolkit for Breast Cancer Survivors
Breast cancer survivors, from diagnosis until the end of life, go through many transitions. One major transition is the significant decrease of physical activity immediately after diagnosis. Despite the known benefits of physical activity-speeding recovery time and reduced cancer recurrence risk-only 1 in 3 survivors met physical activity recommendations of 150 minutes of moderate-intensity activity per week. Physical activity interventions have shown effectiveness in helping breast cancer survivors increase physical activity during treatment, but limited evidence-based physical activity interventions have been incorporated into the clinic and community. To address this limitation, the investigators are partnering with the UTMB breast cancer support group to conduct a 12-week physical activity intervention, Pink Warrior.
The goal of this study is to compare an intervention that uses active games versus an intervention uses pedometer to encourage physical activity such as walking within breast cancer survivors in active cancer treatment. The study will include breast cancer survivor between the ages of 18 - 70 whom currently gets less than 150 minutes of planned physical activity per week and received a breast cancer diagnosis within 0 to 6 months. Participants will be randomized to participate in the support group using the active video game-based physical activity intervention (Wii and Xbox active games) or to participate in the existing UTMB breast cancer support group with pedometers (Digi-Walker CW-700/701). The investigators hypothesize that by engaging in active video gaming, breast cancer survivors will be motivated to initiate and maintain physical activity during treatment. This will ultimately increase functional capacity and prevent functional disability in breast cancer survivors.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Increasing and maintaining physical activity among female breast cancer (BC) survivors during treatment remains an unresolved problem in BC survivorship care. BC survivors, from diagnosis until the end of life, go through many transitions. One major transition is the significant decline of physical activity immediately after diagnosis. Despite the known benefits of physical activity-speeding recovery time and reduced cancer recurrence risk-less than 30% of survivors met physical activity recommendations. Physical activity interventions have shown effectiveness in helping BC survivors increase activity during treatment, but limited evidence-based activity interventions have been disseminated into the clinic and community. To address this limitation, we are partnering with the UTMB breast cancer support group to conduct a 12-week physical activity intervention, Pink Warrior, which will investigate the feasibility of implementing active video game-based physical activity intervention among BC survivors undergoing treatment within the support group setting. Participants (N = 60) will be randomized to participate in the support group using the active video game-based physical activity intervention or to participate in the existing UTMB breast cancer support group with pedometers. Our specific aims are:
Aim 1: Evaluate the feasibility and acceptability of active video game-based physical activity intervention among BC survivors undergoing treatment within the support group setting. Measures of feasibility will include weekly attendance records, number of completed home-based worksheets, number of participants completing the program activities, technological issues, and adverse events.
Aim 2: Compare the support group using the active video game-based physical activity intervention to the existing UTMB breast cancer support group with pedometer. Primary outcomes will be changes in physical activity. Secondary outcomes will be changes in physical function, dietary pattern, and quality of life.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Texas
-
Galveston, Texas, Estados Unidos, 77550
- The University of Texas Medical Branch
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Provide informed consent
- Diagnosed with primary female breast cancer within 0 to 6 months period of time
- English-speaking between the ages of 18 and 70
- Able to read and write in English
- Obtained approval from oncologists for the participant to be involved in the physical activity based support group
- Able to travel to the UTMB Breast Health Center
- Able to move arms and legs as well as ambulate
- Able to see TV screen from a distance of 2 to 4 feet
Exclusion Criteria:
- Being pregnant
- Dementia
- Currently engage in ≥150 minutes of planned moderate physical activity per week for the prior week
- Are involved in another physical activity intervention
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Active video game-based intervention
This arm will receive the active video game-based intervention, which will include attending 12 weekly group sessions at the UTMB Breast Health Clinic, participate in self-paced home session, and monitor daily, weekly, and monthly steps using Wii Fit Meter.
All participant will be provided a water bottle and a tote bag as a token of appreciation for participation.
|
|
|
Comparador activo: Pedometer
This arm will receive the pedometer intervention, which will include attending 3 monthly UTMB Breast Cancer Support Group sessions, and monitor daily, weekly, and monthly steps using a pedometer (Digit-Walker CW-700/701).
All participant will be provided a water bottle and a tote bag as a token of appreciation for participation.
|
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in physical activity steps per day as measured by an Actigraph monitor
Periodo de tiempo: Change in steps per day from baseline to 14 weeks
|
Change in steps per day between 14 weeks and baseline as measured by an Actigraph monitor
|
Change in steps per day from baseline to 14 weeks
|
|
Change in physical activity minutes as measured by an Actigraph monitor
Periodo de tiempo: Change in physical activity minutes from baseline to 14 weeks
|
Change in physical activity minutes between 14 weeks and baseline as measured by an Actigraph monitor
|
Change in physical activity minutes from baseline to 14 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in physical function as measured by the Short Physical Performance Battery (SPPB)
Periodo de tiempo: Change in physical function from baseline and 14 weeks
|
The SPPB consists of six components: repeated chair sit and stands, balance test, semi-tandem stand, tandem stand, side-by-side stand, and eight feet walk
|
Change in physical function from baseline and 14 weeks
|
|
Change in dietary pattern as measured by the Dietary Screener Questionnaire
Periodo de tiempo: Change in dietary pattern from baseline and 14 weeks
|
Change in dietary pattern from baseline and 14 weeks] [Safety Issue: No] The Dietary Screener Questionnaire used in the National Health and Nutrition Examination Survey 2009-10.
The screener captures frequency of fruits, vegetables, dairy/calcium, added sugar, whole grains/fiber, red meat, and processed meat consumption within the past 30 days
|
Change in dietary pattern from baseline and 14 weeks
|
|
Change in quality of life as measured by the Functional Assessment of Cancer Therapy-Breast measure
Periodo de tiempo: Change in quality of life from baseline and 14 weeks
|
Changes in physical, social, emotional, functional, and additional well-being between 14 weeks and baseline as measured by FACT-B
|
Change in quality of life from baseline and 14 weeks
|
|
Change in hand grip strength as measured by hand dynamometer
Periodo de tiempo: Change in hand grip strength from baseline to 14 weeks
|
Hand dynamometer estimates the muscle strength generated from flexor muscles of the hand and the forearm
|
Change in hand grip strength from baseline to 14 weeks
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in weight
Periodo de tiempo: Change in weight from baseline to 14 weeks
|
Change in body weight between 14 weeks and baseline as measured by a weight scale in the clinic
|
Change in weight from baseline to 14 weeks
|
|
Change in waist circumference
Periodo de tiempo: Change in waist circumference from baseline to 14 weeks
|
Change in waist circumference between 14 weeks and baseline as measured by Seca-203
|
Change in waist circumference from baseline to 14 weeks
|
|
Change in physical activity minutes, measured by the Community Healthy Activities Model Program for Seniors
Periodo de tiempo: Change in physical activity minutes from baseline to 14 weeks
|
Self-reported physical activity questionnaire
|
Change in physical activity minutes from baseline to 14 weeks
|
|
Change in physical function, measured by PROMIS measure specific to cancer survivors
Periodo de tiempo: Change in physical function from baseline to 14 weeks
|
Changes in overall self-reported physical functions between 14 weeks and baseline as measured by PROMIS-Ca Bank v1.1-Physical
Function
|
Change in physical function from baseline to 14 weeks
|
|
Change in fatigue, measured by PROMIS measure specific to cancer survivors
Periodo de tiempo: Change in fatigue from baseline to 14 weeks
|
Changes in overall self-reported fatigue level between 14 weeks and baseline as measured by PROMIS-Ca Bank v1.1-Fatigue
|
Change in fatigue from baseline to 14 weeks
|
|
Change in exercise motivation, measured by autonomous motivation specific to physical activity
Periodo de tiempo: Change in motivation from baseline to 14 weeks
|
Behavioral regulation in Exercise Questionnaire-2 will be used
|
Change in motivation from baseline to 14 weeks
|
|
Change in psychological feelings, measured by Psychological Need Satisfaction in Exercise Scale
Periodo de tiempo: Change in psychological feelings from baseline to 14 weeks
|
Sub-scales included perceived competence, perceived autonomy, and perceived relatedness
|
Change in psychological feelings from baseline to 14 weeks
|
|
Change in self-regulation, measured by Rovinak et al. scale
Periodo de tiempo: Change in self-regulation from baseline to 14 weeks
|
Sub-scales include exercise goals and exercise plans
|
Change in self-regulation from baseline to 14 weeks
|
|
Feasibility-Adherence
Periodo de tiempo: 14 weeks
|
Adherence will be measured by number of participants who completed at least 80% of the program activities.
|
14 weeks
|
|
Feasibility-Attrition
Periodo de tiempo: 14 weeks
|
Attrition will be measured by percentage of people who dropped out of the intervention program.
|
14 weeks
|
|
Feasibility-Technological Issues
Periodo de tiempo: 14 weeks
|
Technological issues will be measured by counting number of occurrence
|
14 weeks
|
|
Feasibility-Adverse Events
Periodo de tiempo: 14 weeks
|
Adverse events will be measured by counting number of occurrence
|
14 weeks
|
|
Acceptability
Periodo de tiempo: 14 weeks
|
Participant acceptability and satisfaction will be assessed by a questionnaire with 5-point scale responses
|
14 weeks
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Maria Swartz, PhD, MPH, The University of Texas Medical Branch
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 16-0040
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .